Optimal design of clinical trials comparing several treatments with a control

Pharmaceutical Statistics

Volumn 6, Issue 1, 2007, Pages 23-33

  Marschner, Ian C ^a  

^a PFIZER INC   (United States)

Author keywords

Clinical trials; Combination therapy; Multiple comparisons; Optimal design; Power; Unbalanced allocation

Indexed keywords

AMLODIPINE; ATORVASTATIN; CHOLESTEROL; PLACEBO;

ARTICLE; BONE DENSITY; CHOLESTEROL BLOOD LEVEL; CLINICAL RESEARCH; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; DYSLIPIDEMIA; HUMAN; HYPERTENSION; METHODOLOGY; MONOTHERAPY; NULL HYPOTHESIS; OSTEOPOROSIS; OUTCOME ASSESSMENT; PROBABILITY; SAMPLE SIZE; STATISTICAL ANALYSIS; VARIANCE;

CONTROLLED CLINICAL TRIALS; DATA INTERPRETATION, STATISTICAL; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; HUMANS; MODELS, STATISTICAL; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 33947395676     PISSN: 15391604     EISSN: 15391612     Source Type: Journal    
DOI: 10.1002/pst.240     Document Type: Article

References (14)

1. Fleiss JL. The design and analysis of clinical experiments. Wiley: New York, 1986; p. 96.
2. Hedayat AS, Jacroux M, Majumdar D. Optimal designs for comparing test treatments with controls. Statistical Science 1988; 3:462-491.
3. Zhu W, Wong WK. Optimal treatment allocation in comparative biomedical studies. Statistics in Medicine 2000; 19:639-648.
4. Dunnett CW. A multiple comparison procedure for comparing several treatments with a control. Journal of the American Statistical Association 1955; 50:1096-1121.
5. Westfall PH, Tobias RD, Randall D, Rom D, Wolfinger RD, Hochberg Y. Multiple comparisons and multiple tests. SAS Institute Inc.: Cary, 1999.
6. Berger RL, Hsu JC. Bioequivalence trials, intersection-union tests and equivalence confidence sets. Statistical Science 1996; 11:283-319.
7. ICH. Guideline E9: statistical issues in clinical trials. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). 1998. Accessed at www.ich.org.
8. EMEA. Points to consider on multiplicity issues in clinical trials. European Medicines Agency (EMEA), 2002. Accessed at www.emea.eu.int.
9. Horn M, Vollandt R. A manual for the determination of sample sizes for multiple comparisons: formulas and tables. Informatik, Biometrie und Epidemiologie 2001; 32:1-38.
10. Horn M, Vollandt R. Sample size for comparisons of k treatments with a control based on different definitions of power. Biometrical Journal 1998; 40:589-612.
11. Hochberg Y, Tamhane AC. Multiple comparison procedures. Wiley: New York, 1987.
12. Serfling RJ. Multivariate symmetry and asymmetry. In Encyclopedia of statistical sciences (2nd edn), Balakrishnan N, Read CB, Vidakovic B (eds). Wiley: New York, 2004.
13. R Development Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing: Vienna, 2004. ISBN 3-900051-00-3, URL http://www.R-project.org.
14. Hasselblad V, Allen AS. Power calculations for large multi-arm placebo-controlled studies of dichotomous outcomes. Statistics in Medicine 2003; 22:1943-1954.